Stopping GLP-1 medications doubles risk of major heart events: study @CP24
Stopping GLP-1 medications doubles risk of major heart events: study  @CP24
Uploaded November 2026 | Updated November 2026, 1 day ago
A new European study suggests that Type 2 diabetes patients who stop taking popular GLP-1 medications face twice the risk of a major cardiac event.

Subscribe to CP24 to watch more videos: youtube.com/Cp24TorontoBreakingNews

Connect with CP24:
For the latest news: cp24.com
For the latest videos: cp24.com/video
CP24 Live and Interactive: cp24.com/now
CP24 on Twitter: twitter.com/CP24
CP24 on TikTok: tiktok.com/@cp24breakingnews
CP24 Breakfast on Twitter: twitter.com/CP24Breakfast
---
CP24 is Toronto's #1 source for breaking news.
Subscribe for more:
CTV News: youtube.com/ctvnews
BNN Bloomberg: youtube.com/@BNNBloomberg
W5: youtube.com/@OfficialW5

#CP24 #torontonews #canadiannews
Stopping GLP-1 medications doubles risk of major heart events: study17-year-old boy wanted on Canada-wide warrant for two murders, 16-year-old arrested: policeImages released of suspect accused of stealing credit cards and jewelrySpadina streetcars will likely be out of service for couple of days: TTCFirefighters forced their way down chimney in deadly Scarborough house fire, officials saysPolice make arrest in Toronto Bridle Path home invasion caseWoman killed after exiting vehicle following highway 401 crashMilestones for November 12, 2026Stellantis came to see us for money | Joly explains how federal government has a part in the deal‘We are here to continue crying about the loss of our son’: Community mourns 18-year-old Malik AbbasOne person dead after Scarborough house fireDozens of U.S. flights at Toronto Pearson Airport have been cancelled
CP24 |

Stopping GLP-1 medications doubles risk of major heart events: study

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER